{
    "startDate": "2017-01-01",
    "endDate": "2017-09-30",
    "year": "2017",
    "quarter": "Q3",
    "symbol": "AVEO",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 16354000
            },
            {
                "label": "Marketable securities",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 21055000
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 2375000
            },
            {
                "label": "Clinical trial retainers current.",
                "concept": "aveo:ClinicalTrialRetainersCurrent",
                "unit": "usd",
                "value": 1274000
            },
            {
                "label": "Other prepaid expenses and other assets current.",
                "concept": "aveo:OtherPrepaidExpensesAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 470000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 41528000
            },
            {
                "label": "Clinical trial retainers non current.",
                "concept": "aveo:ClinicalTrialRetainersNonCurrent",
                "unit": "usd",
                "value": 165000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 18000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 41711000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1941000
            },
            {
                "label": "Accrued clinical trial costs and contract research current.",
                "concept": "aveo:AccruedClinicalTrialCostsAndContractResearchCurrent",
                "unit": "usd",
                "value": 7496000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1621000
            },
            {
                "label": "Loans payable, net of discount",
                "concept": "LoansPayableCurrent",
                "unit": "usd",
                "value": 4920000
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueCurrent",
                "unit": "usd",
                "value": 395000
            },
            {
                "label": "Deferred research and development reimbursement current.",
                "concept": "aveo:DeferredResearchAndDevelopmentReimbursementCurrent",
                "unit": "usd",
                "value": 935000
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 540000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 17848000
            },
            {
                "label": "Loans payable, net of current portion and discount",
                "concept": "LongTermLoansPayable",
                "unit": "usd",
                "value": 14324000
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueNoncurrent",
                "unit": "usd",
                "value": 1401000
            },
            {
                "label": "Deferred research and development reimbursement noncurrent.",
                "concept": "aveo:DeferredResearchAndDevelopmentReimbursementNoncurrent",
                "unit": "usd",
                "value": 459000
            },
            {
                "label": "Warrant liability (Note 7)",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 51953000
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 300000
            },
            {
                "label": "Liabilities and stockholders\u2019 deficit",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 86285000
            },
            {
                "label": "Preferred stock, $.001 par value: 5,000 shares authorized at September 30, 2017 and December 31, 2016; no shares issued and outstanding as of September 30, 2017 and December 31, 2016",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $.001 par value: 250,000 shares authorized and 118,321 shares issued and outstanding at September 30, 2017; and 200,000 shares authorized and 75,863 shares issued and outstanding at December 31, 2016",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 118000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 545774000
            },
            {
                "label": "Accumulated other comprehensive income (loss)",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -590468000
            },
            {
                "label": "Stockholders\u2019 deficit:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -44574000
            },
            {
                "label": "Liabilities and stockholders\u2019 deficit",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 41711000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -68524000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 774000
            },
            {
                "label": "Non-cash interest expense",
                "concept": "PaidInKindInterest",
                "unit": "usd",
                "value": 391000
            },
            {
                "label": "Change in fair value of warrant liability",
                "concept": "AdjustmentOfWarrantsGrantedForServices",
                "unit": "usd",
                "value": 47947000
            },
            {
                "label": "Amortization of premium and discount on investments",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": -36000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 1348000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -196000
            },
            {
                "label": "Other noncurrent assets",
                "concept": "IncreaseDecreaseInOtherNoncurrentAssets",
                "unit": "usd",
                "value": -787000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -245000
            },
            {
                "label": "Increase decrease in accrued contract research.",
                "concept": "aveo:IncreaseDecreaseInAccruedContractResearch",
                "unit": "usd",
                "value": 3498000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "IncreaseDecreaseInOtherAccruedLiabilities",
                "unit": "usd",
                "value": 90000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": -411000
            },
            {
                "label": "Increase decrease in deferred research and development reimbursement.",
                "concept": "aveo:IncreaseDecreaseInDeferredResearchAndDevelopmentReimbursement",
                "unit": "usd",
                "value": 1394000
            },
            {
                "label": "Operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -15415000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireMarketableSecurities",
                "unit": "usd",
                "value": 27793000
            },
            {
                "label": "Proceeds from maturities and sales of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
                "unit": "usd",
                "value": 14950000
            },
            {
                "label": "Investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -12843000
            },
            {
                "label": "Proceeds from issuance of common stock, net of issuance costs",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 21294000
            },
            {
                "label": "Proceeds from issuance of common stock to related party.",
                "concept": "aveo:ProceedsFromIssuanceOfCommonStockToRelatedParty",
                "unit": "usd",
                "value": 3210000
            },
            {
                "label": "Proceeds from issuance of stock for stock-based compensation arrangements",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
                "unit": "usd",
                "value": 12000
            },
            {
                "label": "Proceeds from issuance of loan payable",
                "concept": "ProceedsFromLinesOfCredit",
                "unit": "usd",
                "value": 5000000
            },
            {
                "label": "Financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
                "unit": "usd",
                "value": 29516000
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 1258000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaid",
                "unit": "usd",
                "value": 1468000
            }
        ],
        "ic": [
            {
                "label": "Collaboration and licensing revenue",
                "concept": "Revenues",
                "unit": "usd",
                "value": 7497000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 19503000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 6734000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 26237000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -18740000
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 1736000
            },
            {
                "label": "Change in fair value of warrant liability",
                "concept": "AdjustmentOfWarrantsGrantedForServices",
                "unit": "usd",
                "value": 47947000
            },
            {
                "label": "Other expense, net:",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -49683000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -68423000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 101000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -68524000
            },
            {
                "label": "Net loss per share \u2014 basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.67
            },
            {
                "label": "Weighted average number of common shares outstanding",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 101754000
            },
            {
                "label": "Unrealized gain (loss) on available-for-sale securities",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -4000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -68528000
            }
        ]
    }
}